Trials / Sponsors / Center Trials & Treatment
Center Trials & Treatment
Academic / Other · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Comparison of Safety and Clinical Benefit of Injections Subcutaneously Talazoparib Versus Oral Talazoparib in Advanced or Recurrent Solid Tumors, Breast Neoplasm | Phase 1 | 2022-11-10 |
| Terminated | A Randomized Study to Determine the Expression of the Furin Protein in Patients With SARS-CoV-2 and Vaccinated COVID-19, SARS-CoV-2, Furin | — | 2022-08-10 |
| Withdrawn | Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma Recurrent Glioblastoma, Gliosarcoma, Anaplastic Gliomas | Phase 1 | 2018-07-17 |
| No Longer Available | Expanded Access for Pembrolizumab (MK-3475) Melanoma (Skin), Melanoma Recurrent, Glioblastoma Multiforme | — | — |
| No Longer Available | An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas Glioblastoma, Glioma of Brain | — | — |